EGRX
Eagle Pharmaceuticals, Inc.
EGRX
EGRX
Delisted
EGRX was delisted on the 2nd of October, 2024.
183 hedge funds and large institutions have $751M invested in Eagle Pharmaceuticals, Inc. in 2019 Q3 according to their latest regulatory filings, with 17 funds opening new positions, 57 increasing their positions, 73 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
1% less capital invested
Capital invested by funds: $756M → $751M (-$4.85M)
22% less repeat investments, than reductions
Existing positions increased: 57 | Existing positions reduced: 73
Holders
183
Holding in Top 10
3
Calls
$4.24M
Puts
$1.99M
Top Buyers
| 1 | +$12.3M | |
| 2 | +$3.24M | |
| 3 | +$2.38M | |
| 4 |
Renaissance Technologies
New York
|
+$2.05M |
| 5 |
ZIM
Zacks Investment Management
Chicago,
Illinois
|
+$2.05M |
Top Sellers
| 1 | -$11.7M | |
| 2 | -$6.49M | |
| 3 | -$5.58M | |
| 4 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
-$3.47M |
| 5 |
Invesco
Atlanta,
Georgia
|
-$2.74M |